Infantile Spasms Therapeutics Market Data Survey Report 2013-2025
Table of Content
1 Global Market Overview
- 1.1 Scope of Statistics
- 1.1.1 Scope of Products
- 1.1.2 Scope of Manufacturers
- 1.1.3 Scope of End-Use
- 1.1.4 Scope of Product Type
- 1.1.5 Scope of Regions/Countries
- 1.2 Global Market Size
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2015-2019 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Size and CAGR 2015-2019 (Volume)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Infantile Spasms Therapeutics Market Forecast and CAGR 2020-2025 (Volume)
2 Regional Market
- 2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
- 2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
- 2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 Key Manufacturers
- 3.1 H. Lundbeck
- 3.1.1 Company Information
Tab Company Profile List of H. Lundbeck
- 3.1.2 Product & Services
- 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of H. Lundbeck
- 3.1.4 Recent Development
- 3.2.1 Company Information
Tab Company Profile List of Mallinckrodt
- 3.2.2 Product & Services
- 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mallinckrodt
- 3.2.4 Recent Development
- 3.3.1 Company Information
Tab Company Profile List of Insys Therapeutics
- 3.3.2 Product & Services
- 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Insys Therapeutics
- 3.3.4 Recent Development
- 3.4.1 Company Information
Tab Company Profile List of Orphelia Pharma
- 3.4.2 Product & Services
- 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Orphelia Pharma
- 3.4.4 Recent Development
- 3.5.1 Company Information
Tab Company Profile List of Valerion Therapeutics
- 3.5.2 Product & Services
- 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Valerion Therapeutics
- 3.5.4 Recent Development
- 3.6.1 Company Information
Tab Company Profile List of Catalyst Pharmaceuticals
- 3.6.2 Product & Services
- 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Catalyst Pharmaceuticals
- 3.6.4 Recent Development
- 3.7.1 Company Information
Tab Company Profile List of Anavex Life Sciences
- 3.7.2 Product & Services
- 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Anavex Life Sciences
- 3.8 Retrophin
- 3.8.1 Company Information
Tab Company Profile List of Retrophin
- 3.8.2 Product & Services
- 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Retrophin
4 Major End-Use
- 4.1 Hospital
- 4.1.1 Overview
Tab Summary of Consumption Distribution of Hospital
- 4.1.2 Hospital Market Size and Forecast
Fig Hospital Market Size and CAGR 2015-2019 (Million USD)
Fig Hospital Market Size and CAGR 2015-2019 (Volume)
Fig Hospital Market Forecast and CAGR 2020-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2020-2025 (Volume)
- 4.2 Clinic
- 4.2.1 Overview
Tab Summary of Consumption Distribution of Clinic
- 4.2.2 Clinic Market Size and Forecast
Fig Clinic Market Size and CAGR 2015-2019 (Million USD)
Fig Clinic Market Size and CAGR 2015-2019 (Volume)
Fig Clinic Market Forecast and CAGR 2020-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2020-2025 (Volume)
- 4.3 Others
- 4.3.1 Overview
Tab Summary of Consumption Distribution of Others
- 4.3.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
5 Market by Type
- 5.1 Oral
- 5.1.1 Overview
Tab Product Overview of Oral
- 5.1.2 Oral Market Size and Forecast
Fig Oral Market Size and CAGR 2015-2019 (Million USD)
Fig Oral Market Size and CAGR 2015-2019 (Volume)
Fig Oral Market Forecast and CAGR 2020-2025 (Million USD)
Fig Oral Market Forecast and CAGR 2020-2025 (Volume)
- 5.2 Injection
- 5.2.1 Overview
Tab Product Overview of Injection
- 5.2.2 Injection Market Size and Forecast
Fig Injection Market Size and CAGR 2015-2019 (Million USD)
Fig Injection Market Size and CAGR 2015-2019 (Volume)
Fig Injection Market Forecast and CAGR 2020-2025 (Million USD)
Fig Injection Market Forecast and CAGR 2020-2025 (Volume)
6 Price Overview
- 6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
- 6.2 Price by End-Use
Tab Different Products Prices List of End-Use
- 6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 Conclusion
Summary
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
H. Lundbeck
Mallinckrodt
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
Major applications as follows:
Hospital
Clinic
Others
Major Type as follows:
Oral
Injection
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa